健腰通络丸联合揿针治疗肝肾亏虚型腰痛临床研究
Clinical Research on Jianyao Tongluo Wan Combined with Pressing Needles in the Treatment of Low Back Pain Caused by Deficiency of Liver and Kidney
摘要: 目的:探究健腰通络丸联合揿针治疗肝肾亏虚型腰痛的临床疗效。方法:选取2018年10月至2024年12月在十堰市中医医院诊治的肝肾亏虚型腰痛患者200例,随机分为对照组和治疗组,每组各100例,对照组给予常规治疗,治疗组除常规治疗外,加用健腰通络丸口服及揿针治疗。对比两组的临床疗效、中医症候积分、VAS评分、JOA评分及生活质量评分。结果:治疗组总有效率显著高于对照组(P < 0.05);治疗组中医症候积分、VAS评分显著低于对照组,JOA评分及生活质量评分显著高于对照组(P < 0.05)。结论:健腰通络丸联合揿针治疗肝肾亏虚型腰痛疗效确切,能有效改善临床症状,提高患者生活质量。
Abstract: Objective: To investigate the clinical efficacy of Jianyao Tongluo Wan combined with press needle in the treatment of low back pain due to liver and kidney deficiency. Methods: A total of 200 patients with low back pain of liver and kidney deficiency type, diagnosed and treated at Shiyan Traditional Chinese Medicine Hospital from October 2018 to December 2024, were selected. They were randomly divided into a control group and a treatment group, with 100 cases in each group. The control group received conventional treatment. In addition to conventional treatment, the treatment group was given oral Jianyao Tongluo Wan and treated with press needles. The clinical efficacy, Traditional Chinese Medicine (TCM) syndrome scores, Visual Analog Scale (VAS) scores, Japanese Orthopaedic Association (JOA) scores, and quality of life scores were compared between the two groups. Results: The total effective rate in the treatment group was significantly higher than that in the control group (P < 0.05). The TCM syndrome scores and VAS scores in the treatment group were significantly lower than those in the control group, while the JOA scores and quality of life scores were significantly higher than those in the control group (P < 0.05). Conclusion: The combination of Jianyao Tongluo Wan and press needle has a definite therapeutic effect in the treatment of low back pain due to liver and kidney deficiency. It can effectively improve clinical symptoms and enhance the quality of life for patients.
参考文献
|
[1]
|
国家卫生健康委能力建设和继续教育中心疼痛病诊疗专项能力提升项目专家组. 中国慢性腰背痛诊疗指南 (2024版) [J]. 中华疼痛学杂志, 2024, 20(1): 1-20.
|
|
[2]
|
巢元方. 诸病源候论[M]. 北京: 人民卫生出版社, 1955.
|
|
[3]
|
张伯礼. 中医内科学[M]. 北京: 中国中医药出版社, 2017: 316-320.
|
|
[4]
|
刘存志. 皮内针疗法临床应用专家共识[J]. 中国针灸, 2021, 41(2): 113-118.
|
|
[5]
|
中华医学会骨科学分会脊柱外科学组. 腰椎间盘突出症诊疗指南(2022年版) [J]. 中华骨科杂志, 2022, 42(16): 993-1008.
|
|
[6]
|
国家中医药管理局. 中医病证诊断疗效标准(ZY/T001.1-94) [M]. 南京: 南京大学出版社, 1994.
|
|
[7]
|
郑筱萸. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 2002: 346-349.
|
|
[8]
|
周仲瑛, 吴勉华. 中医内科学[M]. 第4版. 北京: 中国中医药出版社, 2021: 45-51.
|
|
[9]
|
中华医学会疼痛学分会. 疼痛评估与治疗临床实践指南(2020版) [J]. 中华疼痛学杂志, 2020, 16(6): 401-435.
|
|
[10]
|
李鲁, 王红妹, 沈毅. SF-36 健康调查量表中文版的研制及其性能测试[J]. 中华预防医学杂志, 2002, 36(2): 38-42.
|
|
[11]
|
灵枢·终始[M]. 北京: 人民卫生出版社, 2017.
|
|
[12]
|
中华中医药学会针灸分会. 皮内针疗法临床应用指南[J]. 中国针灸, 2023, 43(8): 889-894.
|
|
[13]
|
国家中医药管理局针灸基础研究重点实验室. 皮内针中枢调节效应的多模态影像学研究[R]. 北京: 国家中医药管理局, 2024.
|
|
[14]
|
中国外用NSAIDs治疗急慢性肌肉骨骼疼痛的合理用药多学科指南协作组. 中国外用NSAIDs治疗急慢性肌肉骨骼疼痛的合理用药多学科指南(2022版) [J]. 中国全科医学, 2023, 26(12): 1401-1412.
|